As of April 16, 2025, Orion Corporation (ORNAV.HE) has a market cap of $7.94 billion USD. According to our data, Orion Corporation is ranked No.1898 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $7.94 B |
403.15%
|
Dec 29, 2024 | $1.58 B |
13.16%
|
Dec 28, 2023 | $1.39 B |
-20.33%
|
Dec 29, 2022 | $1.75 B |
46.77%
|
Dec 29, 2021 | $1.19 B |
0.51%
|
Dec 29, 2020 | $1.19 B |
-5.73%
|
Dec 29, 2019 | $1.26 B |
41.33%
|
Dec 27, 2018 | $0.89 B |
-0.82%
|
Dec 28, 2017 | $0.90 B |
-24.03%
|
Dec 29, 2016 | $1.18 B |
39.15%
|
Dec 29, 2015 | $0.85 B |
33.12%
|
Dec 29, 2014 | $0.64 B |
30.03%
|
Dec 29, 2013 | $0.49 B |
-1.94%
|
Dec 30, 2012 | $0.50 B |
46.30%
|
Dec 29, 2011 | $0.34 B |
-0.44%
|
Dec 30, 2010 | $0.34 B |
9.52%
|
Dec 29, 2009 | $0.31 B |
35.73%
|
Dec 29, 2008 | $0.23 B |
-20.12%
|
Dec 27, 2007 | $0.29 B |
3.83%
|
Dec 28, 2006 | $0.28 B |
5.26%
|
Dec 29, 2005 | $0.26 B |
29.46%
|
Dec 30, 2004 | $0.20 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
Market Cap | = | ORNAV.HE Stock Price | * | ORNAV.HE Shares Outstanding |
= | $56.35 | * | 32.75 M | |
= | $7.94 B |